Seelos Therapeutics
(NASDAQ:SEEL)
$0.423
-0.013[-2.98%]
Last update: 9:25AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Seelos Therapeutics Stock (NASDAQ:SEEL), Quotes and News Summary

Seelos Therapeutics Stock (NASDAQ: SEEL) stock price, news, charts, stock research, profile.

Open$0.436
Close-
Volume / Avg.348.661K / 425.953K
Day Range0.390 - 0.440
52 Wk Range0.368 - 49.800
Market Cap$5.787M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
28
Short Interest
5.42%
Days to Cover1

Recent News

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.
Avi Kapoor
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday. The Dow traded up 0.63% to 39,034.59 while the NASDAQ rose 0.35% to 16,160.20. The S&P 500 also rose, gaining, 0.41% to 5,170.36.
Avi Kapoor
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Seelos Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on dev...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SEEL
CING

FAQ

Q

How do I buy Seelos Therapeutics (SEEL) stock?

A

You can purchase shares of Seelos Therapeutics (NASDAQ: SEEL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Seelos Therapeutics's (SEEL) competitors?

A

Other companies in Seelos Therapeutics’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Universe Pharmaceuticals (NASDAQ:UPC), Palisade Bio (NASDAQ:PALI) and Hepion Pharmaceuticals (NASDAQ:HEPA).

Q

What is the target price for Seelos Therapeutics (SEEL) stock?

A

The latest price target for Seelos Therapeutics (NASDAQ: SEEL) was reported by Guggenheim on Friday, September 22, 2023. The analyst firm set a price target for 0.00 expecting SEEL to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Seelos Therapeutics (SEEL)?

A

The stock price for Seelos Therapeutics (NASDAQ: SEEL) is $0.4 last updated Today at April 16, 2024 at 12:19 PM EDT.

Q

Does Seelos Therapeutics (SEEL) pay a dividend?

A

There are no upcoming dividends for Seelos Therapeutics.

Q

When is Seelos Therapeutics (NASDAQ:SEEL) reporting earnings?

A

Seelos Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Seelos Therapeutics (SEEL) going to split?

A

There is no upcoming split for Seelos Therapeutics.

Q

What sector and industry does Seelos Therapeutics (SEEL) operate in?

A

Seelos Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch